[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100550981":3},{"organization":4,"outcomesModule":7,"designInfo":17,"detailedDescription":16,"studyPopulation":20,"armGroups":21,"interventions":30,"overallOfficials":16,"centralContacts":16,"locations":34,"responsibleParty":83,"collaborators":86,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":97,"sex":98,"minAge":99,"maxAge":100,"enrollmentInfo":101,"targetDuration":104,"studyType":105,"phases":16,"briefSummary":106,"conditions":107,"keywords":16,"overallStatus":56,"whyStopped":16,"lastUpdateSubmitDate":109,"lastUpdatePostDateStruct":110,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":118},{"fullName":5,"class":6},"Seoul National University Hospital","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":12,"otherOutcomes":16},[9],{"measure":10,"description":10,"timeFrame":11},"Remission of gastric MALT lymphoma","Within 3 years from diagnosis",[13],{"measure":14,"description":14,"timeFrame":15},"Eradication of H. pylori infection","Within 6 month from eradication therapy",null,{"allocation":16,"interventionModel":16,"interventionModelDescription":16,"primaryPurpose":16,"observationalModel":18,"timePerspective":19,"maskingInfo":16},"COHORT","PROSPECTIVE","Eligible patients who visited participating hospital will be asked, and upon providing informed consent, will be enrolled in the study.",[22,27],{"label":23,"type":16,"description":24,"interventionNames":25},"MALT lymphoma","Patients who were newly diagnosed as gastric MALT lymphoma",[26],"Other: MALT lymphoma",{"label":28,"type":16,"description":29,"interventionNames":16},"Control group","Patients who underwent\n\n1. diagnosed upper endoscopy for dyspepsia and had chronic gastritis,\n2. therapeutic upper endoscopy for gastric hyperplastic polyps, or\n3. screening upper endoscopy without any symptoms.",[31],{"type":6,"name":23,"description":32,"armGroupLabels":33,"otherNames":16},"New diagnosis with gastric MALT lymphoma",[23],[35,54,69],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":16,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"Korea University Ansan Hospital","NOT_YET_RECRUITING","Ansan-si","Gyeonggi-do","15355","South Korea",{"type":43,"coordinates":44},"Point",[45,46],126.82194,37.32361,{"lat":46,"lon":45},[49],{"name":50,"role":51,"phone":52,"phoneExt":16,"email":53},"Ayoung Lee, MD. PhD.","CONTACT","82-31-412-5114","frisby@naver.com",{"facility":55,"status":56,"city":57,"state":39,"zip":58,"country":41,"countryCode":16,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Cheol Min Shin","RECRUITING","Seongnam-si","463-707",{"type":43,"coordinates":60},[61,62],127.13778,37.43861,{"lat":62,"lon":61},[65],{"name":66,"role":51,"phone":67,"phoneExt":16,"email":68},"Cheol Min Shin, M.D., Ph.D.","+ 82-31-787-7057","scm6md@gmail.com",{"facility":70,"status":56,"city":71,"state":16,"zip":72,"country":41,"countryCode":16,"cosmosGeoPoint":73,"geoPoint":77,"contacts":78},"Kangbuk Samsung Hospital","Seoul","03181",{"type":43,"coordinates":74},[75,76],126.9784,37.566,{"lat":76,"lon":75},[79],{"name":80,"role":51,"phone":81,"phoneExt":16,"email":82},"Hyo-Joon Yang, MD. PhD.","82-2-2001-8330","hyojoon.yang@samsung.com",{"type":84,"investigatorFullName":55,"investigatorTitle":85,"investigatorAffiliation":5,"oldNameTitle":16,"oldOrganization":16},"PRINCIPAL_INVESTIGATOR","Professor",[87,88],{"name":70,"class":6},{"name":36,"class":6},"100550981","cohort-study-for-gastric-malt-lymphoma-100550981",false,"NCT06454149","Cohort Study for Gastric MALT Lymphoma","Establishment of a Cohort for Investigating the Pathophysiology of Gastric MALT Lymphoma","HUG-MALToma","Inclusion Criteria:\n\n\\[MALT lymphoma group\\]\n\n* Newly diagnosed as gastric MALT lymphoma \\[Control group\\]\n* Patients who underwent\n\n  1. diagnosed upper endoscopy for dyspepsia and had chronic gastritis,\n  2. therapeutic upper endoscopy for gastric hyperplastic polyps, or\n  3. screening upper endoscopy without any symptoms.\n\nExclusion Criteria:\n\n* History of gastric or other malignancy\n* Use of antibiotics or probiotics within 4 weeks\n* Uncontrolled chronic illnesses",true,"ALL","18 Years","75 Years",{"count":102,"type":103},300,"ESTIMATED","3 Years","OBSERVATIONAL","The goal of this observational study is to establish clinical data and tissue repository in patients with gastric MALT lymphoma and controls.\n\nParticipants will be asked to provide clinical information and various tissues (saliva, gastric mucosa, and feces).",[108],"Gastric MALT Lymphoma","2026-09-25",{"date":111,"type":112},"2026-09-28","ACTUAL",{"date":114,"type":112},"2024-06-06",{"date":116,"type":103},"2031-06-05",{"name":5,"class":6},3]